<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5</volume><submitter>Martinez R</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Growth hormone secretagogues (GHS), among other factors, regulate the release of GH. The biological activity of the secretagogue peptide A233 as a promoter of growth and innate immunity in teleost fish has previously been demonstrated, but its role in the immune system of mammals is not well understood.&lt;h4>Methods&lt;/h4>The effect of the peptide was investigated in J774A.2 macrophage cells using a comparative proteomics approach after 6 and 12 h of peptide stimulation.&lt;h4>Results&lt;/h4>The functional analysis of differentially modulated proteins showed that A233 peptide treatment appears to promote activation and ROS-dependent cytotoxic functions in macrophages and enhanced expression of antiviral protein complexes such as MAVS. In accordance with this hypothesis, we found t</pubmed_abstract><journal>Biochemistry and biophysics reports</journal><pagination>379-387</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5600417</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Comparative proteomic analysis of growth hormone secretagogue A233 treatment of murine macrophage cells J774A.2 indicates it has a role in antiviral innate response.</pubmed_title><pmcid>PMC5600417</pmcid><pubmed_authors>Gonzalez LJ</pubmed_authors><pubmed_authors>Ramos Y</pubmed_authors><pubmed_authors>Besada V</pubmed_authors><pubmed_authors>de Villavicencio-Diaz TN</pubmed_authors><pubmed_authors>Albericio F</pubmed_authors><pubmed_authors>Mendez M</pubmed_authors><pubmed_authors>Vonasek E</pubmed_authors><pubmed_authors>Marcos E</pubmed_authors><pubmed_authors>Hermida L</pubmed_authors><pubmed_authors>Martinez R</pubmed_authors><pubmed_authors>Rodriguez E</pubmed_authors><pubmed_authors>Gonzalez LG</pubmed_authors><pubmed_authors>Garay H</pubmed_authors><pubmed_authors>Sanchez A</pubmed_authors><pubmed_authors>Sanchez B</pubmed_authors><pubmed_authors>Masforrol Y</pubmed_authors><pubmed_authors>Estrada MP</pubmed_authors><pubmed_authors>Ferro JN</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparative proteomic analysis of growth hormone secretagogue A233 treatment of murine macrophage cells J774A.2 indicates it has a role in antiviral innate response.</name><description>&lt;h4>Background&lt;/h4>Growth hormone secretagogues (GHS), among other factors, regulate the release of GH. The biological activity of the secretagogue peptide A233 as a promoter of growth and innate immunity in teleost fish has previously been demonstrated, but its role in the immune system of mammals is not well understood.&lt;h4>Methods&lt;/h4>The effect of the peptide was investigated in J774A.2 macrophage cells using a comparative proteomics approach after 6 and 12 h of peptide stimulation.&lt;h4>Results&lt;/h4>The functional analysis of differentially modulated proteins showed that A233 peptide treatment appears to promote activation and ROS-dependent cytotoxic functions in macrophages and enhanced expression of antiviral protein complexes such as MAVS. In accordance with this hypothesis, we found t</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Mar</publication><modification>2026-04-15T17:10:59.428Z</modification><creation>2025-05-29T16:23:28.967Z</creation></dates><accession>S-EPMC5600417</accession><cross_references><pubmed>28955845</pubmed><doi>10.1016/j.bbrep.2016.01.008</doi></cross_references></HashMap>